Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes from Pinctada martensii mucus can safely reduce melanin production, offering a new treatment for skin pigment issues.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Azithromycin and Roxithromycin can remove aging cells and may help with anti-aging.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Both treatments for localized alopecia areata are equally effective.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Methotrexate improved skin condition in 64% of patients with generalized granuloma annulare.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Suppressing ODC activity reduces tumor growth in hair follicles.

Etanercept effectively treated a severe skin condition when other treatments failed.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

Methotrexate therapy for psoriasis may help regrow hair in some cases of male pattern baldness.

Mesotherapy involves injecting substances like dutasteride, minoxidil, and vitamins into the skin to treat hair loss and skin conditions, with good patient satisfaction but possible skin inflammation.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.